Harmonized Micronutrient Project

August 4, 2014 updated by: Société des Produits Nestlé (SPN)

A New Strategy to Analyze Gene-Nutrient Interaction in Children and Adolescents

The purpose of this trial is to better define how individuals with different genetic make-ups will require different interventions to improve their methylation potential and nutrient status.

Study Overview

Status

Completed

Conditions

Detailed Description

Despite the increasing incidence of overweight and obesity among children, nutritional deficiencies are still a concern.

A low intake of vitamins and minerals is associated with a reduction in the antioxidant capacity. Some vitamins are associated with chronic diseases including overweight and obesity.

S-adenosylmethionine (SAM) and S-adenosylhomocysteine (SAH) are the substrate and product of essential reactions; the SAM:SAH ratio has been associated with health and is an indicator of cellular DNA methylation potential.

Low level of this ratio may affect short and long term health. In this explorative knowledge building open interventional study, subject to be enrolled are children or adolescents 9 to 13 years of age per year (n=180 per year, over 2 years). The study consists of 6 weeks nutritional intervention followed by a 6 weeks follow up.

In this study, genomics, proteomics, lipidomics analysis will be performed, in addition to biochemistry, hematology and vitamins analysis.

Study Type

Interventional

Enrollment (Actual)

146

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • São Paulo
      • Ribeirão Preto, São Paulo, Brazil, 14-049-900
        • Campus Universitário USP, Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

9 years to 13 years (Child)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Children or adolescents 9 to 13 years of age.
  • Clinically stable.
  • Normal weight, overweight and obese.

Exclusion Criteria:

  • Disease diagnosis.
  • At least one episode of axillary temperature >37°C over the prior 15 days.
  • Three or more episodes of liquid or semi-liquid stools over the prior 24 hours.
  • Supplementation with vitamins and/or minerals.
  • On a supervised diet for reducing weight or any other type of diet restriction.
  • Currently participating or having participated in another clinical study during the last 4 weeks prior to the beginning of this study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: micronutrient supplementation

All the enrolled subjects will recieve orally, onca a day, during school days a chocolate bar including vitamins and minerals.

The micronitrient supplementation will be consumed over 6 weeks, 5 days/week.

Other Names:
  • Nestrovit: white chocolate bar with vitamins and minerals

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
SAM/SAH ratio
Time Frame: baseline and after 6 weeks of product intake
Change from baseline in the correlation between the SAM/SAH ratio in erythrocytes, dietary intakes and, polymorphisms in genes associated with micronutrients
baseline and after 6 weeks of product intake

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
SNP arrays, proteomics, metabolomics, micronutrient levels
Time Frame: baseline, after 6 weeks of product intake and after 6 weeks of follow up
Composite secondary outome: extensive "omic" analysis and correlation of the data over the 3 timepoints
baseline, after 6 weeks of product intake and after 6 weeks of follow up
SAM/SAH ratio
Time Frame: after 6 weeks product intake and after 6 weeks of follow up
Change between 6 weeks after product intake and 6 weeks of follow up in the correlation between the SAM/SAH ratio in erythrocytes, dietary intakes and, polymorphisms in genes associated with micronutrients
after 6 weeks product intake and after 6 weeks of follow up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jacqueline Pontes Monteiro, Profa. Dra., Campus Universitário USP, Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2013

Primary Completion (Actual)

June 1, 2014

Study Completion (Actual)

June 1, 2014

Study Registration Dates

First Submitted

March 26, 2013

First Submitted That Met QC Criteria

March 29, 2013

First Posted (Estimate)

April 4, 2013

Study Record Updates

Last Update Posted (Estimate)

August 5, 2014

Last Update Submitted That Met QC Criteria

August 4, 2014

Last Verified

August 1, 2014

More Information

Terms related to this study

Other Study ID Numbers

  • 12.07.NIHS

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Genomic

Clinical Trials on micronutrient supplementation

Subscribe